With the aim of guaranteeing safety during blood transfusions, Progenika has developed and validated 1,000 clinical samples in cooperation with the principal European blood banks. Concretely, the validation of these samples was 99.8%, considerably higher than that produced using the current serology technique, which produces an error of 3%.
Thus, BLOODchip is currently the safest and most precise technique for genetically determining blood groups, enabling the reduction of adverse reactions in blood transfusions.
Two different techniques are currently used to detect possible incompatibilities in blood transfusions: the serological method and DNA sequencing. The serological technique has a limited capacity and does not allow the detection of 3% of the incompatibilities existing. DNA sequencing, while overcoming this drawback of the serological method, is however a slow and costly system.
Progenika has developed BLOODchip to respond to the disadvantages of the current systems. In this way, the totality of blood group incompatibilities are detected in a safer, quicker and more specific analytical process than with the serological technique. Moreover, its cost is twenty times less than DNA sequencing, which enables its generalized and routine use in all blood transfusions.
The BLOODchip is the result of research within the remit of the European Union IV Framework Programme and undertaken by Progenika in collaboration with the principal European blood banks.
It should be pointed out that Progenika Biopharma has developed and patented various products that are already on the market for several types of diagnosis (for diagnoses, prognoses and the prediction of and response to treatment of human diseases). So, in 2004 Progenika launched the LIPOchip on to the market, for the diagnosis of Family Hypercholesterolemia, the first biochip with the CE label and on sale since 2004. Progenika currently has 3 products that are at a development phase and which will finalise at the end of the year.
Progenika has managed to become the international technological leader in the field of developing genetic biochips. Biochips enable the simultaneous analysis of genetic variables, multiplying the capacity of conventional techniques for the diagnosis of illness, prognosticating its aggressiveness and progression and predicting the response of the patient to treatment.
Irati Kortabitarte | alfa
Building a brain, cell by cell: Researchers make a mini neuron network (of two)
23.05.2018 | Institute of Industrial Science, The University of Tokyo
Research reveals how order first appears in liquid crystals
23.05.2018 | Brown University
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
23.05.2018 | Life Sciences
23.05.2018 | Physics and Astronomy
23.05.2018 | Life Sciences